|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1224369927 |
| 003 |
OCoLC |
| 005 |
20231120010521.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
201128s2020 cau o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OPELS
|d OCLCO
|d UAB
|d EBLCP
|d OCL
|d OCLCO
|d OCLCQ
|d COM
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1224004303
|
| 020 |
|
|
|a 9780128210963
|
| 020 |
|
|
|a 0128210966
|
| 020 |
|
|
|z 9780128210956
|
| 020 |
|
|
|z 0128210958
|
| 035 |
|
|
|a (OCoLC)1224369927
|z (OCoLC)1224004303
|
| 050 |
|
4 |
|a R857.N34
|
| 082 |
0 |
4 |
|a 610.28
|
| 245 |
0 |
0 |
|a Nanoformulation strategies for cancer treatment /
|c edited by Sarwar Beg [and more].
|
| 260 |
|
|
|a San Diego :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource (403 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Micro and Nano Technologies Ser.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover -- Nanoformulation Strategies for Cancer Treatment -- Copyright Page -- Contents -- List of contributors -- A. General consideration on cancer nanomedicines -- 1 Nanomedicine for combinational anticancer drug therapeutics: Recent advances, challenges, and future perspectives -- 1.1 Introduction -- 1.2 Various barriers to overcome in cancer treatment -- 1.3 Combinational anticancer therapeutic approach -- 1.3.1 Polyplexes -- 1.3.2 Liposomes -- 1.3.3 Micelles -- 1.3.4 Dendrimers -- 1.3.5 Host-guest supramolecular chemistry -- 1.3.6 Inorganic systems
|
| 505 |
8 |
|
|a 1.3.7 Other dual-drug delivery systems -- 1.4 Conclusions and future perspectives -- References -- 2 Market research in cancer therapeutics: New and generic product development -- 2.1 Introduction -- 2.2 Cancer therapeutics -- 2.3 Prevention -- 2.4 Early detection and screening -- 2.5 Diagnosis and treatment -- 2.6 Overall strategies -- 2.7 New and generic product development in the pharmaceutical industry -- 2.8 Developing a plan for marketing and selling specialist therapies -- 2.9 Creating a marketing and sales function that is fit for the future -- 2.10 Conclusions and future perspectives
|
| 505 |
8 |
|
|a 4 Biopharmaceutical challenges in using lipid nanoparticles for oral chemotherapy -- 4.1 Introduction -- 4.2 Biopharmaceutical chemotherapy obstacles -- 4.3 Lipid nanoparticles for oral cancer chemotherapy -- 4.3.1 Rationale -- 4.3.2 Recent developments -- 4.3.3 Solid lipid nanoparticles -- 4.3.4 Nanostructured lipid carriers -- 4.3.5 Lipid-drug conjugates -- 4.4 Pharmacokinetics of lipid nanoparticles -- 4.4.1 Biodistribution -- 4.4.2 Metabolism and elimination -- 4.5 Future recommendations and conclusion -- References -- Further reading
|
| 505 |
8 |
|
|a 5 Polymeric nanoparticles for potential drug delivery applications in cancer -- 5.1 Introduction -- 5.2 Rationale to use polymeric nanoparticles in cancer therapy -- 5.3 Advantages of polymeric nanoparticles -- 5.4 Disadvantages of polymeric nanoparticles -- 5.5 Factors considered during the development of nanoformulations -- 5.6 Polymers used for polymeric nanoparticles -- 5.6.1 Natural hydrophilic polymers -- 5.6.2 Synthetic hydrophobic polymer -- 5.7 Mechanisms of nanoparticles uptake by the cancer cells -- 5.7.1 Targeting of polymeric nanoparticles to cancer cells -- 5.7.1.1 Passive targeting
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Nanochemistry.
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|0 (CaQQLa)201-0004693
|
| 650 |
|
6 |
|a Nanochimie.
|0 (CaQQLa)000258433
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
7 |
|a Nanochemistry
|2 fast
|0 (OCoLC)fst01741250
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst00845538
|
| 700 |
1 |
|
|a Beg, Sarwar,
|d 1987-
|
| 700 |
1 |
|
|a Rahman, Mahfoozur.
|
| 700 |
1 |
|
|a Choudhry, Hani.
|
| 700 |
1 |
|
|a Souto, Eliana B.
|
| 700 |
1 |
|
|a Ahmad, Farhan J.
|
| 776 |
0 |
8 |
|i Print version:
|a Beg, Sarwar.
|t Nanoformulation Strategies for Cancer Treatment.
|d San Diego : Elsevier, �2020
|
| 830 |
|
0 |
|a Micro & nano technologies.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128210956
|z Texto completo
|
